Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Ratio

log₂ of a cancer’s share of deaths divided by its share of active interventional trials, both computed over the eligible top-level cancers of the scope. 0 = trial share matches death share; +1 = twice as many deaths as trials would suggest; −1 = half. Scale-free, so it can be compared across scopes, unlike the percentile-based Trial Gap Index.

Computedci-trial-gap-ratio-v1unit: log₂ ratiohigher = worseAll metrics

Top 15 by Trial Gap RatioMalignant Colon Neoplasm+2.72Malignant Gallbladder Neoplasm+2.32Cutaneous Melanoma+2.01Malignant Laryngeal Neoplasm+1.17Malignant Pancreatic Neoplasm+1.05Malignant Bladder Neoplasm+0.87Malignant Lung Neoplasm+0.82Skin Carcinoma+0.64Malignant Lip and Oral Cavity…+0.4Malignant Rectal Neoplasm+0.34Malignant Liver Neoplasm+0.29Malignant Kidney Neoplasm+0.29Malignant Esophageal Neoplasm+0.19Malignant Vulvar Neoplasm+0.07Malignant Prostate Neoplasm-0.12
RankΔCancerTrial Gap Ratio (log₂ ratio)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+2.72100High confidencecdc-wonderclinicaltrials
inputs
deaths
40801
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.074626
thresholds
minDeaths
100
minActivity
1
trialShare
0.011322
activeTrials
225
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9322
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580336

2=Malignant Gallbladder Neoplasm+2.3297.1High confidencecdc-wonderclinicaltrials
inputs
deaths
4402
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.008051
thresholds
minDeaths
100
minActivity
1
trialShare
0.00161
activeTrials
32
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9574
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580337

3=Cutaneous Melanoma+2.0194.1High confidencecdc-wonderclinicaltrials
inputs
deaths
8671
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.01586
thresholds
minDeaths
100
minActivity
1
trialShare
0.003925
activeTrials
78
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9826
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580338

4=Malignant Laryngeal Neoplasm+1.1791.2High confidencecdc-wonderclinicaltrials
inputs
deaths
4095
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.00749
thresholds
minDeaths
100
minActivity
1
trialShare
0.003321
activeTrials
66
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9700
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580339

5=Malignant Pancreatic Neoplasm+1.0588.2High confidencecdc-wonderclinicaltrials
inputs
deaths
51327
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.093879
thresholds
minDeaths
100
minActivity
1
trialShare
0.045491
activeTrials
904
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9637
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580340

6=Malignant Bladder Neoplasm+0.8785.3High confidencecdc-wonderclinicaltrials
inputs
deaths
17396
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.031818
thresholds
minDeaths
100
minActivity
1
trialShare
0.017411
activeTrials
346
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10702
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580341

7=Malignant Lung Neoplasm+0.8282.4High confidencecdc-wonderclinicaltrials
inputs
deaths
128762
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.23551
thresholds
minDeaths
100
minActivity
1
trialShare
0.133052
activeTrials
2644
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9763
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580342

8=Skin Carcinoma+0.6479.4High confidencecdc-wonderclinicaltrials
inputs
deaths
5462
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.00999
thresholds
minDeaths
100
minActivity
1
trialShare
0.006391
activeTrials
127
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9889
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580343

9=Malignant Lip and Oral Cavity Neoplasm+0.476.5High confidencecdc-wonderclinicaltrials
inputs
deaths
5424
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.009921
thresholds
minDeaths
100
minActivity
1
trialShare
0.007498
activeTrials
149
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
8881
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580344

10=Malignant Rectal Neoplasm+0.3473.5High confidencecdc-wonderclinicaltrials
inputs
deaths
13446
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.024593
thresholds
minDeaths
100
minActivity
1
trialShare
0.019424
activeTrials
386
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9385
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580345

11=Malignant Liver Neoplasm+0.2970.6High confidencecdc-wonderclinicaltrials
inputs
deaths
30532
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.055844
thresholds
minDeaths
100
minActivity
1
trialShare
0.045592
activeTrials
906
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9511
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580346

12=Malignant Kidney Neoplasm+0.2967.6High confidencecdc-wonderclinicaltrials
inputs
deaths
15215
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.027829
thresholds
minDeaths
100
minActivity
1
trialShare
0.022796
activeTrials
453
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10639
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580347

13=Malignant Esophageal Neoplasm+0.1964.7High confidencecdc-wonderclinicaltrials
inputs
deaths
16274
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.029766
thresholds
minDeaths
100
minActivity
1
trialShare
0.026067
activeTrials
518
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9196
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580348

14=Malignant Vulvar Neoplasm+0.0761.8High confidencecdc-wonderclinicaltrials
inputs
deaths
1555
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.002844
thresholds
minDeaths
100
minActivity
1
trialShare
0.002717
activeTrials
54
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10135
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580349

15=Malignant Prostate Neoplasm-0.1258.8High confidencecdc-wonderclinicaltrials
inputs
deaths
34815
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.063678
thresholds
minDeaths
100
minActivity
1
trialShare
0.069193
activeTrials
1375
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10513
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580350

16=Malignant Anal Neoplasm-0.1855.9High confidencecdc-wonderclinicaltrials
inputs
deaths
1651
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.00302
thresholds
minDeaths
100
minActivity
1
trialShare
0.003422
activeTrials
68
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9448
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580351

17=Malignant Oropharyngeal Neoplasm-0.2652.9High confidencecdc-wonderclinicaltrials
inputs
deaths
3286
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.00601
thresholds
minDeaths
100
minActivity
1
trialShare
0.007196
activeTrials
143
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9007
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580352

18=Malignant Central Nervous System Neoplasm-0.2950High confidencecdc-wonderclinicaltrials
inputs
deaths
18523
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.033879
thresholds
minDeaths
100
minActivity
1
trialShare
0.041415
activeTrials
823
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10765
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580353

19=Malignant Mesothelioma-0.3247.1High confidencecdc-wonderclinicaltrials
inputs
deaths
2114
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.003867
thresholds
minDeaths
100
minActivity
1
trialShare
0.004831
activeTrials
96
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9952
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580354

20=Malignant Uterine Corpus Neoplasm-0.3944.1High confidencecdc-wonderclinicaltrials
inputs
deaths
8608
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.015744
thresholds
minDeaths
100
minActivity
1
trialShare
0.020682
activeTrials
411
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10324
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580355

21=Malignant Salivary Gland Neoplasm-0.5641.2High confidencecdc-wonderclinicaltrials
inputs
deaths
1173
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.002145
thresholds
minDeaths
100
minActivity
1
trialShare
0.00317
activeTrials
63
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
8944
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580356

22=Malignant Ovarian Neoplasm-0.5738.2High confidencecdc-wonderclinicaltrials
inputs
deaths
12654
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.023145
thresholds
minDeaths
100
minActivity
1
trialShare
0.03442
activeTrials
684
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10387
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580357

23=Malignant Gastric Neoplasm-0.6735.3High confidencecdc-wonderclinicaltrials
inputs
deaths
11246
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.020569
thresholds
minDeaths
100
minActivity
1
trialShare
0.03281
activeTrials
652
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9259
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580358

24=Malignant Breast Neoplasm-0.7232.4High confidencecdc-wonderclinicaltrials
inputs
deaths
43897
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.080289
thresholds
minDeaths
100
minActivity
1
trialShare
0.132196
activeTrials
2627
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10072
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580359

25=Multiple Myeloma-0.929.4High confidencecdc-wonderclinicaltrials
inputs
deaths
11967
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.021888
thresholds
minDeaths
100
minActivity
1
trialShare
0.040962
activeTrials
814
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
11017
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580360

26=Malignant Vaginal Neoplasm-0.9726.5Medium confidencecdc-wonderclinicaltrials
inputs
deaths
435
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.000796
thresholds
minDeaths
100
minActivity
1
trialShare
0.00156
activeTrials
31
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10198
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580361

27=Leukemia-1.0423.5High confidencecdc-wonderclinicaltrials
inputs
deaths
23740
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.043421
thresholds
minDeaths
100
minActivity
1
trialShare
0.08902
activeTrials
1769
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
11080
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580362

28=Malignant Thyroid Gland Neoplasm-1.1220.6High confidencecdc-wonderclinicaltrials
inputs
deaths
2229
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.004077
thresholds
minDeaths
100
minActivity
1
trialShare
0.008857
activeTrials
176
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10828
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580363

29=Malignant Testicular Neoplasm-1.3617.6Medium confidencecdc-wonderclinicaltrials
inputs
deaths
462
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.000845
thresholds
minDeaths
100
minActivity
1
trialShare
0.002164
activeTrials
43
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10576
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580364

30=Malignant Penile Neoplasm-1.5114.7Medium confidencecdc-wonderclinicaltrials
inputs
deaths
415
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.000759
thresholds
minDeaths
100
minActivity
1
trialShare
0.002164
activeTrials
43
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10450
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580365

31=Malignant Hypopharyngeal Neoplasm-1.5511.8Medium confidencecdc-wonderclinicaltrials
inputs
deaths
498
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.000911
thresholds
minDeaths
100
minActivity
1
trialShare
0.002667
activeTrials
53
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9133
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580366

32=Non-Hodgkin Lymphoma-1.598.8High confidencecdc-wonderclinicaltrials
inputs
deaths
19882
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.036365
thresholds
minDeaths
100
minActivity
1
trialShare
0.109098
activeTrials
2168
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10954
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580367

33=Malignant Cervical Neoplasm-1.725.9High confidencecdc-wonderclinicaltrials
inputs
deaths
4207
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.007695
thresholds
minDeaths
100
minActivity
1
trialShare
0.025413
activeTrials
505
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10261
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580368

34=Hodgkin Lymphoma-2.442.9Medium confidencecdc-wonderclinicaltrials
inputs
deaths
909
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.001663
thresholds
minDeaths
100
minActivity
1
trialShare
0.009008
activeTrials
179
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
10891
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580369

35=Malignant Nasopharyngeal Neoplasm-3.430Medium confidencecdc-wonderclinicaltrials
inputs
deaths
664
formula
log2( (deaths / Σ deaths) / (active_trials / Σ active_trials) ) over eligible top-level cancers (deaths ≥ 100, active_trials ≥ 1)
sumDeaths
546737
deathShare
0.001214
thresholds
minDeaths
100
minActivity
1
trialShare
0.013134
activeTrials
261
burdenSourceId
CI-SOURCE-00000011
sumActiveTrials
19872
eligibleEntities
35
countersComputedAt
2026-09-29 02:00:20.557824-04
mortalityObservationId
9070
componentsFormulaVersion
ci-research-gap-components-v1

ranking row 2580370

Data updated 16 hours agoSource updated unknown35 eligible entities · inputs hash e52171cf876028dd79f9840c